Ontario’s Phase Two Vaccine Rollout to Include Trucking Industry


The Ford Government today announced Phase Two of the province’s Vaccination Plan which will run from April to July. During this period, industry workers that cannot work from home will be vaccinated through various pharmacies, site-specific clinics, mobile sites and public health units. As part of the transportation, warehousing and distribution sector, the trucking industry will be a part of the Phase Two group of vaccination priority.

The Phase Two vaccination strategy will involve seniors from ages 60-79 and other at-risk members of the population, including populations located in hot spots as identified by the medical community. A listing of medically eligible conditions was identified by the province and is provided below for your reference.

The group of occupational workers that are categorized as “cannot work from home,” can expect to be vaccinated over the June-July period. Based on the plan, it is expected that members of the trucking industry that do not suffer from certain medical conditions as outlined below, are not located in hot spots or fall below the age of 60, should be eligible to receive vaccinations in July. This would occur after groups like teachers, police, firefighters and food workers are vaccinated.

“OTA would once again like to thank the Ford Government for its leadership during this crisis and for the inclusion of our sector in the Phase Two of the vaccination roll-out,” said OTA President and CEO Stephen Laskowski.

Eligible Health Conditions

Individuals with the following health conditions will be vaccinated in Phase 2:


  • Organ transplant recipients
  • Hematopoietic stem cell transplant recipients
  • People with neurological diseases in which respiratory function may be compromised (e.g., motor neuroin disease, myasthenia gravis, multiple sclerosis)
  • Haematological malignancy diagnosed <1 year
  • Kidney disease eGFR<30


  • Obesity (BMI >40)
  • Other treatments causing immunosuppression (e.g., chemotherapy, immunity weakening medications)
  • Intellectual or developmental disabilities (e.g., Down Syndrome)


  • Immune deficiencies/autoimmune disorders
  • Stroke/cerebrovascular disease
  • Dementia
  • Diabetes
  • Liver disease
  • All other cancers
  • Respiratory diseases
  • Spleen problems
  • Heart disease
  • Hypertension with end organ damage
  • Diagnosis of mental disorder
  • Substance use disorders
  • Thalassemia
  • Pregnancy
  • Immunocompromising health conditions
  • Other disabilities requiring direct support care in the community


Scroll to Top